SolarEdge stock jumps over 10% as TD Cowen upgrade puts SEDG back in play
12 January 2026
1 min read

SolarEdge stock jumps over 10% as TD Cowen upgrade puts SEDG back in play

NEW YORK, Jan 12, 2026, 12:54 EST — Regular session

  • SolarEdge shares climbed 10.6%, hitting $36.38 by midday trading
  • TD Cowen raises its rating to “buy” and bumps the price target up to $38
  • Solar stocks also rise as attention turns to upcoming earnings and margin forecasts

Shares of SolarEdge Technologies surged 10.6%, hitting $36.38 by midday Monday following a TD Cowen upgrade. The analyst lifted the price target to $38 from $34. The stock peaked at $36.39 earlier, with roughly 2.2 million shares changing hands. 1

This bounce is significant since SolarEdge serves as a high-beta play on the solar equipment cycle. The stock reacts sharply to sentiment changes, often attracting momentum traders and short-term hedgers in the process.

The timing is tricky for the group. Investors are wrestling with whether rooftop solar demand is leveling off or merely taking a breather amid inventory clearances. Meanwhile, manufacturers are pushing “turnaround” narratives that depend on margins staying steady through 2026.

TD Cowen’s Jeff Osborne and his team zeroed in on execution as the key to the turnaround. They highlighted “financial strength, market share expansion, innovation, and U.S. manufacturing” as the main pillars driving progress, they wrote. 2

The note also highlighted SolarEdge’s growing U.S. production and exports, which may qualify for the 45X credit—a U.S. tax incentive rewarding manufacturers for making specific clean-energy parts domestically. The broker anticipates an investor day in the spring that could shift margin targets. 3

Shares tied to solar saw gains too. Enphase Energy climbed 6.1%, Sunrun jumped 6.0%, and the Invesco Solar ETF rose 4.2%. The S&P 500 tracker SPY, however, barely moved.

SolarEdge offers inverters and power optimizers installed between solar panels and the grid. These devices convert the panels’ output into usable electricity and control production at the module level. As a result, the company’s performance closely tracks installation volumes, dealer stock levels, and how quickly new projects get signed by homeowners and businesses.

The backdrop remains complicated. At times, demand for residential solar in Europe has fallen off as electricity prices softened and Chinese competitors ramped up their presence, Reuters reported in earlier coverage of the company. 4

Yet the boost from an analyst call rarely lasts. A hiccup in shipments, fresh price cuts, or weaker-than-expected margin gains could quickly derail the upgrade story and bring the downside risks back into focus.

SolarEdge hasn’t set a date for its earnings release yet, but Nasdaq projects the report will drop around Feb. 18. Investors are focused on any 2026 guidance, particularly around gross margin, and hope for a clearer schedule for the upcoming investor day. 5

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Rivian stock (RIVN) ticks up as Wolfe downgrade warns of bigger cash burn
Previous Story

Rivian stock (RIVN) ticks up as Wolfe downgrade warns of bigger cash burn

Qualcomm stock tumbles while chip ETFs rise — Apple modem fears return before CPI, earnings
Next Story

Qualcomm stock tumbles while chip ETFs rise — Apple modem fears return before CPI, earnings

Go toTop